Results 151 to 160 of about 2,321,749 (354)
Long-Term Examination of Water Chemistry Changes Following Treatment of Cyanobacterial Bloom with Coagulants and Minerals. [PDF]
Lee B +6 more
europepmc +1 more source
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon +13 more
wiley +1 more source
Effects of sex and soil water chemistry on leaf morphology and physiology of Myrica gale var. tomentosa. [PDF]
Mizuki I +6 more
europepmc +1 more source
Comment on “Modeling the Effects of Acid Deposition: Assessment of a Lumped Parameter Model of Soil Water and Streamwater Chemistry” by B. J. Cosby et al. [PDF]
Richard Hooper, Charles T. Driscoll
openalex +1 more source
Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li +10 more
wiley +1 more source
Chemical Weathering and CO2 Consumption Inferred from Riverine Water Chemistry in the Xi River Drainage, South China. [PDF]
Zhao Y +5 more
europepmc +1 more source
Nanosecond infrared laser (NIRL) low‐volume sampling combined with shotgun lipidomics uncovers distinct lipidome alterations in oropharyngeal squamous cell carcinoma (OPSCC) of the palatine tonsil. Several lipid species consistently differentiate tumor from healthy tissue, highlighting their potential as diagnostic markers.
Leonard Kerkhoff +11 more
wiley +1 more source
Hydrography and water chemistry of the open Mediterranean Sea
Klaus Kremling, Hauke Petersen
openalex +1 more source
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala +15 more
wiley +1 more source

